104 related articles for article (PubMed ID: 27158022)
1. Evaluating the consistency of location of the most severe acute skin reaction and highest skin dose measured by thermoluminescent dosimeter during radiotherapy for breast cancer.
Sun LM; Huang CJ; Chen HY; Chang GH; Tsao MJ
Med Dosim; 2016; 41(3):216-20. PubMed ID: 27158022
[TBL] [Abstract][Full Text] [Related]
2. Using a thermoluminescent dosimeter to evaluate the location reliability of the highest-skin dose area detected by treatment planning in radiotherapy for breast cancer.
Sun LM; Huang CJ; Chen HY; Meng FY; Lu TH; Tsao MJ
Med Dosim; 2014; 39(4):348-53. PubMed ID: 25113812
[TBL] [Abstract][Full Text] [Related]
3. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
4. Evaluation the consistency of location of moist desquamation and skin high dose area for breast cancer patients receiving adjuvant radiotherapy after breast conservative surgery.
Sun LM; Huang EY; Liang JA; Meng FY; Chang GH; Tsao MJ
Radiat Oncol; 2013 Mar; 8():50. PubMed ID: 23497574
[TBL] [Abstract][Full Text] [Related]
5. Skin-sparing helical tomotherapy vs 3D-conformal radiotherapy for adjuvant breast radiotherapy: in vivo skin dosimetry study.
Capelle L; Warkentin H; Mackenzie M; Joseph K; Gabos Z; Pervez N; Tankel K; Chafe S; Amanie J; Ghosh S; Parliament M; Abdulkarim B
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e583-90. PubMed ID: 22580119
[TBL] [Abstract][Full Text] [Related]
6. Surface dose measurement and comparison between TLD and OSLD during modified re constructive mastectomy irradiation.
K E R; Krishnan M
Biomed Phys Eng Express; 2024 May; 10(4):. PubMed ID: 38714180
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on skin dose measurement using MOSFET and TLD for pediatric patients with acute lymphatic leukemia.
Al-Mohammed HI; Mahyoub FH; Moftah BA
Med Sci Monit; 2010 Jul; 16(7):CR325-9. PubMed ID: 20581774
[TBL] [Abstract][Full Text] [Related]
8. The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial.
Venables K; Miles EA; Aird EG; Hoskin PJ;
Radiother Oncol; 2004 Jun; 71(3):303-10. PubMed ID: 15172146
[TBL] [Abstract][Full Text] [Related]
9. Thermoluminescence dosimetry for skin dose assessment during intraoperative radiotherapy for early breast cancer.
Fogg P; Das KR; Kron T; Fox C; Chua B; Hagekyriakou J
Australas Phys Eng Sci Med; 2010 Jun; 33(2):211-4. PubMed ID: 20617469
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry of MammoSite® applicator: comparison between Monte Carlo simulation, measurements, and treatment planning calculation.
Oshaghi M; Sadeghi M; Mahdavi SR; Shirazi A
J Cancer Res Ther; 2013; 9(2):224-9. PubMed ID: 23771363
[TBL] [Abstract][Full Text] [Related]
11. TLD extrapolation for skin dose determination in vivo.
Kron T; Butson M; Hunt F; Denham J
Radiother Oncol; 1996 Nov; 41(2):119-23. PubMed ID: 9004353
[TBL] [Abstract][Full Text] [Related]
12. Skin dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy.
Kinhikar RA; Murthy V; Goel V; Tambe CM; Dhote DS; Deshpande DD
Appl Radiat Isot; 2009 Sep; 67(9):1683-5. PubMed ID: 19369084
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry around metallic ports in tissue expanders in patients receiving postmastectomy radiation therapy: an ex vivo evaluation.
Moni J; Graves-Ditman M; Cederna P; Griffith K; Krueger EA; Fraass BA; Pierce LJ
Med Dosim; 2004; 29(1):49-54. PubMed ID: 15023393
[TBL] [Abstract][Full Text] [Related]
14. Suitability of laser stimulated TLD arrays as patient dose monitors in high dose x-ray imaging.
Geise RA; Schueler BA; Lien W; Jones SC
Med Phys; 1997 Oct; 24(10):1643-6. PubMed ID: 9350720
[TBL] [Abstract][Full Text] [Related]
15. A comparison between skin dose of breast cancer patients at the breast region, measured by thermoluminescent dosimeter in the presence and absence of bolus.
Farhood B; Bahreyni Toossi MT; Ghatei N; Mohamadian N; Mozaffari A; Knaup C
J Cancer Res Ther; 2018; 14(6):1214-1219. PubMed ID: 30488832
[TBL] [Abstract][Full Text] [Related]
16. In vivo dosimetry for single-fraction targeted intraoperative radiotherapy (TARGIT) for breast cancer.
Eaton DJ; Best B; Brew-Graves C; Duck S; Ghaus T; Gonzalez R; Pigott K; Reynolds C; Williams NR; Keshtgar MR
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e819-24. PubMed ID: 22300571
[TBL] [Abstract][Full Text] [Related]
17. Verification of calculated skin doses in postmastectomy helical tomotherapy.
Ito S; Parker BC; Levine R; Sanders ME; Fontenot J; Gibbons J; Hogstrom K
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):584-91. PubMed ID: 21300469
[TBL] [Abstract][Full Text] [Related]
18. X-ray surface dose measurements using TLD extrapolation.
Kron T; Elliot A; Wong T; Showell G; Clubb B; Metcalfe P
Med Phys; 1993; 20(3):703-11. PubMed ID: 8350822
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a three-dimensional radiochromic film stack dosimeter for megavoltage photon beam dosimetry.
McCaw TJ; Micka JA; DeWerd LA
Med Phys; 2014 May; 41(5):052104. PubMed ID: 24784393
[TBL] [Abstract][Full Text] [Related]
20. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients.
Pastore F; Conson M; D'Avino V; Palma G; Liuzzi R; Solla R; Farella A; Salvatore M; Cella L; Pacelli R
Acta Oncol; 2016; 55(4):466-73. PubMed ID: 26623532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
